PancraGEN^® is a unique, DNA-based, integrated molecular pathology test that assesses the risk of cancer in pancreatic cysts, helping you to optimally manage each individual patient.

By adding PancraGen^® to first line testing, you can more confidently choose appropriate surveillance strategies or surgical options for patients with pancreatic cysts.